Hematological and Cardiac Marker Values of Adult Male Wistar Rats Administered a Combination of Common Antimalarial Drugs and Ciprofloxacin
Asian Journal of Research in Biochemistry, Volume 12, Issue 2,
This work investigated the possible effects of the administration of artemether-lumefantrine Ciprofloxacin, and their combinations on haematological parameters and cardiac biomarkers of adult male Wistar rats. A total of 20 rats were used for this study, the rats were divided into four groups of five rats each. Animals in group 1 served as control (distilled water), and Group 2 rats received 20/120g/kg body weight of artemether-lumefantrine. Group 3 rats received 125mg/kg body weight of ciprofloxacin. Group 4 took a combination of 20/120g/kg body weight of artemether-lumefantrine and 125mg/kg body weight of ciprofloxacin. The drugs were administered orally for 14 days. At the end of the experimental period, the rats were sacrificed and blood samples and heart tissues were collected for biochemical analysis. The results of this study showed that there was no significant (p<0.05) alteration in relative heart weight in all the test groups when compared to the control (group 1). However, the serum level of troponin, myoglobin and creatinine-kinase MB were significantly (p<0.05) elevated in group 4 animals treated with a combination of artemether-lumefantrine plus ciprofloxacin (group 4 when compared to control (group 1). The haematological results also showed that there was a significant (p<0.05) decrease in the plasma level of PCV, HB, RBC and WBC in group 4 animals when compared to control (group 1). The histological heart examination showed no pathological changes. However, changes in haematological indices and serum activities of diagnostic proteins of cardiac origin should be taken into account.
- hematological parameters
- cardiac markers
How to Cite
Okwakpam FN, Nwonodi MA, Obediah G, Azuonwu OO. Evaluation of chronic administration of the concomitant combination of artemether-lumefantrine and ciprofloxacin on reproductive hormones and prostate specific antigen of adult male Wistar rats. Biomed J. Sci. & Tech Res. 2023;48(3):39770-39775.
Sarah DA, Dillta S, Lucia S, Federica P, Denise PI, Pasquale F, Serena D. The use of antimalarial drugs against viral infection. Public Medical. 2020;8(1): 85.
Amany AS, Nada AA, Ahmed AA. The journey of antimalarial drugs against SARS COV-2. Information in Medicine. 2021; 10(2):100-106.
WHO. World Malaria Report 2019. World Health Organization; 2018.
Available:https://www.who.int/malaria/publications/world-malaria-report2019/en/ Accessed on April 16, 2020.
Agarwal D, Sharma M, Dixit SK, Dutta RK, Singh AK, Gupta RD, Awasthi SK. In vitro synergistic effect of fluoroquinolone analogues in combination with artemisinin against Plasmodium falciparum; their antiplasmodial action in rodent malaria model. Malaria Journal, 2015;14:48. Available:https://doi.org/10.1186/s12936-015-0561-2
Drishtic A, Manish S, Sandeep KD, Koshan KD, Ashok KR, Rinkoo DG, Satish KA. In vitro synergistic effect of fluoroquinolone analogues in combination with artemisinen against plasmodrum falciparum; their antiplasmodal action in rodent malaria. Biomedical Central. 2015; 10(11):051-056.
WHO. Guidelines for the Treatment of Malaria, World Health Organization, Geneva, Switzerland; 2010.
Available:https://apps.who.int/iris/handle/10665/162441 Accessed on April 18th 2020.
Andrade AA, Varottide FDP and Freitas IO. Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin. European Journal of Pharmacology. 2007; 558(1–3):194–198.
Ejikeme UC, Peace MEU and Chinaza OO. Effect of combined quinine and ciprofloxacin therapy in experimental murine plasmodiasis. International Journal of Tropical Disease & Health. 2014;4(3):344–351.
Ubulom PME, Udobi CE and Madu MI. Amodiaquine and Ciprofloxacin Combination in plasmodiasis therapy. Journal of Tropical Medicine. 2015; 947390.
WHO. WHO Position Statement: Effectiveness of non-pharmaceutical forms of Artemisia Annua against Malaria. Geneva, Switzerland; 2012. Available:https://www.who.int/malaria/position_statement_herbal_remedy_artemisia_annua_l.pdf
Accessed on April 18th, 2020.
Otuechere CA, Edewor G, Kale OE, Ekor M. Subacute Therapeutic dosing of artemether-lumefantrine and artesunate-amodiaquine combination preserves plasma cholesterol, renal antioxidant status, and organ weights in rats. Malaria Research and Treatment. 2012;1–5.
Ndem JI, Sylvanus PU, Bassey UE, Effiong BO and Ewere EG. Assessing the effect of concomitant administration of artemether-lumefantrine and ciprofloxacin on some cardiac parameters in wistar rats: The remedial role of vitamin E. GSC Biological and Pharmaceutical Sciences. 2021;17(01): 094–104.
Obaleye JA, Akinremi CA, Balogun EA, Adebayo JO. Toxicological studies and antimicrobial properties of some Iron (III) complexes of ciprofloxacin. African Journal of Biotechnology. 2007;6(24): 2826–2832.
Enendu AC, Unekwe PC, Esimone CO, Obi E, Chilaka KC. Protective effect of phenylalanine and glycine on chloramphenicol-induced bone marrow toxicity in albino rats infected with Klebsiella pneumoniae. International Journal of Biological and Chemical Sciences. 2016;10(1):369-383.
Kahn CM, Scott L. General and introductory veterinary medicine. Merck veterinary manual (10th edn). Merck & Co. Inc.: London; 2010.
Okolo OA, Adenkola AY, Ogbe RJ. Hematological and biochemical studies on the effect of diclofenac sodium on wistar rattus norvegicus. International Journal of Biological and Chemical Sciences. 2015;10(5),2231-2242.
Basavraj N, Nagoba B, Hartalkar A, Wadher B, Bharat W. Citric acid treatment of large non-healing ulcer in a patient with chronic liver disease. European Journal of General Medicine. 2012;9(3),205-207.
Miyata H, Asanuma F, Iwaki Y, Kimura M, Matsumoto K. Evaluation of myelotoxicity in dietary restricted rats. J. Toxicol. Pathol. 2009;22(1):53-63.
Orinya AO, Adenkola AY, Ogbe RJ. Haematological and biochemical studies on the effect of diclofenac sodium on Wistar Rattus norvegicus. Int. J. Biol. Chem. Sci. 2016;10(5):2231-2242.
Al-faris OJ, Al-Shawi NN, Kako MD. Possible cardiac adverse effects induced by therapeutic doses of ciprofloxacin in juvenile rats. Iraqi Journal of Pharmaceutical Science, 2012;21:22-27.
Erdal T, Sefa L. Investigation of possible cardiac side effects of diclofenac in exercise-treated rats. Biomedical. Research. 2017;28(17):7675-7678.
Okwakpam FN, Abarikwu S and Monanu MO. Impact of administration of diclofenac on cardiac biomarkers of adult male albino rats. Drug Discovery. 2020;15(35):103-107.
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes C. AHA/ACC guideline for the management of patients with non-st-elevation acute coronary syndromes: A report of the American college of cardiology/ American heart association task force on practice guidelines. Journal of American College of Cardiology. 2014;64(24):2654-2687.
Okwakpam FN, Omeodu SI and Uwakwe AA. The effects of diazepam on selected blood enzymes activity and prostate specific antigen of adult male wistar rats. American Journal Biomedical Sciences. 2018;10(3):157-166.
Vassallo L, Benvenuto D, Giovanetti M, Angeletti S, Ciccozzi M. Application of the ARIMA model on the COVID-2019 epidemic dataset. Data in Brief. 2019; 29(10),534-550.
Okwakpam FN, Omeodu SI, Uwakwe AA. Assessment of some biochemical markers in serum of adult male wistar rats administered with bromazepam (Lexotan). Scholars Journal of Applied Medical Sciences. 2018;6(10):4093-4099.
Nasrollah M, Naser S. High creatine kinase (CK)-MB and lactate dehydrogenase in the absence of myocardial injury or infarction: A case report. Journal of Cardiovascular and Thoracic Research. 2014;6(1):69-70.
Abstract View: 22 times
PDF Download: 26 times